This is a Validated Antibody Database (VAD) review about rhesus mac.. FAS, based on 27 published articles (read how Labome selects the articles), using FAS antibody in all methods. It is aimed to help Labome visitors find the most suited FAS antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
FAS synonym: CD95

others
  • flow cytometry; human; loading ...; fig e4d
 FAS antibody (BioLegend, DX2) was used in flow cytometry on human samples (fig e4d). Nature (2019) ncbi
BioLegend
mouse monoclonal (DX2)
  • flow cytometry; human; loading ...; fig 2b
BioLegend FAS antibody (Biolegend, DX2) was used in flow cytometry on human samples (fig 2b). BMC Biol (2021) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; 1:100; loading ...; fig 2i
BioLegend FAS antibody (Biolegend, 305624) was used in flow cytometry on human samples at 1:100 (fig 2i). Nat Med (2021) ncbi
mouse monoclonal (DX2)
  • flow cytometry; mouse; 1:200; loading ...; fig 1h
BioLegend FAS antibody (Biolegend, 305612) was used in flow cytometry on mouse samples at 1:200 (fig 1h). elife (2021) ncbi
mouse monoclonal (DX2)
  • flow cytometry; mouse; 1:1000; loading ...
BioLegend FAS antibody (Biolegend, 305608) was used in flow cytometry on mouse samples at 1:1000. Cell Rep Med (2021) ncbi
mouse monoclonal (DX2)
  • flow cytometry; rhesus macaque; loading ...; fig s3b
BioLegend FAS antibody (BIOLEGEND, 305644) was used in flow cytometry on rhesus macaque samples (fig s3b). Cell (2021) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; loading ...; fig 3a
BioLegend FAS antibody (BioLegend, 305610) was used in flow cytometry on human samples (fig 3a). Immunity (2021) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; 1:100; loading ...
BioLegend FAS antibody (Biolegend, 305642) was used in flow cytometry on human samples at 1:100. bioRxiv (2020) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; loading ...; fig e4d
BioLegend FAS antibody (BioLegend, DX2) was used in flow cytometry on human samples (fig e4d). Nature (2019) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; loading ...; fig 3f, 3g
BioLegend FAS antibody (Biolegend, DX2) was used in flow cytometry on human samples (fig 3f, 3g). Brain Pathol (2020) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; loading ...; fig 2a
BioLegend FAS antibody (BioLegend, 305612) was used in flow cytometry on human samples (fig 2a). Sci Rep (2019) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; loading ...; tbl s1
BioLegend FAS antibody (Biolegend, DX2) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (DX2)
  • flow cytometry; rhesus macaque; loading ...; fig 3a
BioLegend FAS antibody (Biolegend, DX2) was used in flow cytometry on rhesus macaque samples (fig 3a). J Virol (2019) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; loading ...; fig 2a
BioLegend FAS antibody (BioLegend, DX2) was used in flow cytometry on human samples (fig 2a). Int J Infect Dis (2018) ncbi
mouse monoclonal (DX2)
  • flow cytometry; mouse; loading ...; fig s3f
In order to investigate the use of red blood cells expressing disease-associated autoantigenas a means of inducing antigen-specific tolerance, BioLegend FAS antibody (BioLegend, 305622) was used in flow cytometry on mouse samples (fig s3f). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; loading ...; fig 2a
BioLegend FAS antibody (Biolegend, 305607) was used in flow cytometry on human samples (fig 2a). Oncotarget (2017) ncbi
mouse monoclonal (DX2)
  • flow cytometry; rhesus macaque; loading ...; fig 4
BioLegend FAS antibody (BioLegend, DX2) was used in flow cytometry on rhesus macaque samples (fig 4). PLoS Pathog (2016) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; loading ...
BioLegend FAS antibody (BioLegend, Dx2) was used in flow cytometry on human samples . J Exp Med (2016) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; loading ...; fig 1c
In order to investigate how differences in B cell populations may contribute to HIV susceptibility, BioLegend FAS antibody (Biolegend, DX2) was used in flow cytometry on human samples (fig 1c). AIDS Res Hum Retroviruses (2016) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; loading ...; fig 2c
In order to characterize B cells and antibody repertoires from injection drug users, BioLegend FAS antibody (Biolegend, DX2) was used in flow cytometry on human samples (fig 2c). PLoS ONE (2016) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; fig 9c
In order to identify a B cell-intrinsic mechanism by which IFN signaling promotes lupus pathogenesis, BioLegend FAS antibody (BioLegend, DX2) was used in flow cytometry on human samples (fig 9c). J Exp Med (2016) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; loading ...; fig 2a
In order to characterize B and T cells from patients with thrombocytopenia, BioLegend FAS antibody (BioLegend, 305608) was used in flow cytometry on human samples (fig 2a). Haematologica (2016) ncbi
mouse monoclonal (DX2)
  • flow cytometry; rhesus macaque; fig 4
In order to assess the ability of HIV-1 envelope glycoprotein-specific broadly neutralizing monoclonal antibodies to suppress acute simian-human immunodeficiency virus replication in rhesus macaques, BioLegend FAS antibody (Biolegend, DX2) was used in flow cytometry on rhesus macaque samples (fig 4). J Virol (2016) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human
BioLegend FAS antibody (Biolegend, 305612) was used in flow cytometry on human samples . Cancer Lett (2015) ncbi
mouse monoclonal (DX2)
  • flow cytometry; rhesus macaque; fig 4
In order to elucidate how CD8 positive T cells suppress virus replication during simian immunodeficiency virus infection, BioLegend FAS antibody (BioLegend, DX2) was used in flow cytometry on rhesus macaque samples (fig 4). J Virol (2015) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; fig 6
BioLegend FAS antibody (Biolegend, DX2) was used in flow cytometry on human samples (fig 6). Am J Hum Genet (2015) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; 1:40
BioLegend FAS antibody (BioLegend, DX2) was used in flow cytometry on human samples at 1:40. Nat Med (2014) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human
BioLegend FAS antibody (BioLegend, DX2) was used in flow cytometry on human samples . Eur J Immunol (2014) ncbi
Articles Reviewed
  1. Zhu Y, Xie J, Shi J. Rac1/ROCK-driven membrane dynamics promote natural killer cell cytotoxicity via granzyme-induced necroptosis. BMC Biol. 2021;19:140 pubmed publisher
  2. Spiegel J, Patel S, Muffly L, Hossain N, Oak J, Baird J, et al. CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial. Nat Med. 2021;27:1419-1431 pubmed publisher
  3. Jeong D, Kim H, Kim H, Kang M, Jung H, Oh Y, et al. Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2. elife. 2021;10: pubmed publisher
  4. Li N, Torres M, Spetz M, Wang R, Peng L, Tian M, et al. CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice. Cell Rep Med. 2021;2:100297 pubmed publisher
  5. He X, Chandrashekar A, Zahn R, Wegmann F, Yu J, Mercado N, et al. Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques. Cell. 2021;184:3467-3473.e11 pubmed publisher
  6. Szabo P, Dogra P, Gray J, Wells S, Connors T, Weisberg S, et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity. 2021;54:797-814.e6 pubmed publisher
  7. Mathew D, Giles J, Baxter A, Greenplate A, Wu J, Alanio C, et al. Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions. bioRxiv. 2020;: pubmed publisher
  8. Lynn R, Weber E, Sotillo E, Gennert D, Xu P, Good Z, et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature. 2019;576:293-300 pubmed publisher
  9. Fransen N, Crusius J, Smolders J, Mizee M, Van Eden C, Luchetti S, et al. Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms. Brain Pathol. 2020;30:106-119 pubmed publisher
  10. de Jonge K, Ebering A, Nassiri S, Maby El Hajjami H, Ouertatani Sakouhi H, Baumgaertner P, et al. Circulating CD56bright NK cells inversely correlate with survival of melanoma patients. Sci Rep. 2019;9:4487 pubmed publisher
  11. Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A, et al. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. Proc Natl Acad Sci U S A. 2018;115:E11513-E11522 pubmed publisher
  12. Hoang T, Harper J, Pino M, Wang H, Micci L, King C, et al. Bone Marrow-Derived CD4+ T Cells Are Depleted in Simian Immunodeficiency Virus-Infected Macaques and Contribute to the Size of the Replication-Competent Reservoir. J Virol. 2019;93: pubmed publisher
  13. Li M, Zhang W, Liu J, Li M, Zhang Y, Xiong Y, et al. Dynamic changes in the immunological characteristics of T lymphocytes in surviving patients with severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis. 2018;70:72-80 pubmed publisher
  14. Pishesha N, Bilate A, Wibowo M, Huang N, Li Z, Deshycka R, et al. Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease. Proc Natl Acad Sci U S A. 2017;114:3157-3162 pubmed publisher
  15. Ren J, Zhang X, Liu X, Fang C, Jiang S, June C, et al. A versatile system for rapid multiplex genome-edited CAR T cell generation. Oncotarget. 2017;8:17002-17011 pubmed publisher
  16. Berry N, Manoussaka M, Ham C, Ferguson D, Tudor H, Mattiuzzo G, et al. Role of Occult and Post-acute Phase Replication in Protective Immunity Induced with a Novel Live Attenuated SIV Vaccine. PLoS Pathog. 2016;12:e1006083 pubmed publisher
  17. Tagawa T, Albanese M, Bouvet M, Moosmann A, Mautner J, Heissmeyer V, et al. Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing. J Exp Med. 2016;213:2065-80 pubmed publisher
  18. Keefer M, Zheng B, Rosenberg A, Kobie J. Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial. AIDS Res Hum Retroviruses. 2016;32:1143-1148 pubmed
  19. Piepenbrink M, Samuel M, Zheng B, Carter B, Fucile C, Bunce C, et al. Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users. PLoS ONE. 2016;11:e0158641 pubmed publisher
  20. Jackson S, Jacobs H, Arkatkar T, Dam E, Scharping N, Kolhatkar N, et al. B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. J Exp Med. 2016;213:733-50 pubmed publisher
  21. Flint S, Gibson A, Lucas G, Nandigam R, Taylor L, Provan D, et al. A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia. Haematologica. 2016;101:698-706 pubmed publisher
  22. Bolton D, Pegu A, Wang K, McGinnis K, Nason M, Foulds K, et al. Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs. J Virol. 2016;90:1321-32 pubmed publisher
  23. Fernandez L, Valentin J, Zalacain M, Leung W, Patino Garcia A, Perez Martinez A. Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D-NKG2DL dependent manner. Cancer Lett. 2015;368:54-63 pubmed publisher
  24. Chowdhury A, Hayes T, Bosinger S, Lawson B, Vanderford T, Schmitz J, et al. Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques. J Virol. 2015;89:8677-86 pubmed publisher
  25. Lewis M, Vyse S, Shields A, Boeltz S, Gordon P, Spector T, et al. UBE2L3 polymorphism amplifies NF-κB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases. Am J Hum Genet. 2015;96:221-34 pubmed publisher
  26. Gibbons D, Fleming P, Virasami A, Michel M, Sebire N, Costeloe K, et al. Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants. Nat Med. 2014;20:1206-10 pubmed publisher
  27. Kudernatsch R, Letsch A, Guerreiro M, Löbel M, Bauer S, Volk H, et al. Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacity. Eur J Immunol. 2014;44:3532-42 pubmed publisher